Orakl Oncology secures $34M Series A led by Norrsken VC and Singular for AI cancer drug prediction.
Amount Raised
$34 Million
Round Type
Series A
ParisBiotechnologyHealth CareArtificial IntelligenceMedicalTherapeuticsInvestors
Description
Paris-based TechBio company Orakl Oncology has raised $34 million in Series A funding to advance its AI platform for predicting cancer trial outcomes. The round was led by Norrsken VC and Singular, with participation from InfraVia, Serena, Patient Autonome Fund, teampact.ventures, and Plug and Play. The company plans to expand beyond colorectal and pancreatic cancers to lung and gastric cancers, leveraging its AI to predict drug efficacy with 90% accuracy. This brings Orakl's total funding to $50 million since its founding in 2023.
Quick answer
Orakl Oncology raised $34 Million in a Series A round, dated November 12, 2026. Investors: Mostafa El Sayed, Jacques Boitreaud, Stan Polu, Thomas Wolf, Hcvc, Speedinvest, Verve Ventures and Plug And Play. Orakl Oncology is based in Paris, Ile-de-France, France.
- How much did Orakl Oncology raise?
- Orakl Oncology raised $34 Million in a Series A round on November 12, 2026.
- Who invested in Orakl Oncology?
- Mostafa El Sayed, Jacques Boitreaud, Stan Polu, Thomas Wolf, Hcvc, Speedinvest, Verve Ventures and Plug And Play are named as investors in this round.
- What does Orakl Oncology do?
- Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer.
- Where is Orakl Oncology based and how big is it?
- Orakl Oncology is based in Paris, Ile-de-France, France.
- Who are the decision-makers at Orakl Oncology?
- Fundz holds 1 contact at Orakl Oncology. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Orakl Oncology that raised within 45 days of this round, from Fundz verified event records.
- Alterra Labs raised $13M (Seed) on November 10, 2026.
- Alethio raised $90M (Series A) on November 5, 2026.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- ABA Life raised $40M on October 30, 2026.
- Happy Health raised $75M on October 29, 2026.
- StimCardio raised $30M (Series A) on October 29, 2026.
Who to call at Orakl Oncology, and when
A new round usually means Orakl Oncology is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Orakl Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Orakl Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Orakl Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Orakl Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansOrakl Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.